What is the appropriate starting dose for testosterone replacement therapy?

Starting Dose for Testosterone Replacement Therapy

For injectable testosterone enanthate or cypionate, start with 100-200 mg every 2 weeks or 50 mg weekly, targeting mid-normal testosterone levels (400-700 ng/dL). For transdermal gels, start with 50 mg daily (AndroGel 1%) or equivalent formulations, adjusting based on testosterone levels measured after at least 1 week of treatment 1, 2.

Formulation-Specific Starting Doses

Injectable Testosterone (Enanthate/Cypionate)

• Standard approach: 100-200 mg every 2 weeks intramuscularly 3, 2
• Alternative approach: 50 mg weekly for more stable levels 2
• Historical data: 200 mg every 2 weeks or 300 mg every 3 weeks were most effective for suppressing LH to normal while maintaining testosterone in physiologic range 4

The key principle is that smaller doses with more frequent injections maintain testosterone levels more consistently within the normal range compared to larger doses at longer intervals 3, 2. While every-two-week dosing remains convenient, weekly dosing often provides better symptom stability and reduces peak-trough fluctuations 5.

Transdermal Gels

• AndroGel 1%: Start with 50 mg daily (two 25-mg packets) 2
• AndroGel 1.62%: Start with 40.5-81 mg daily 2
• Testim 1%: Start with 50 mg daily 2
• Fortesta 2%: Start with 40 mg daily 2

Transdermal preparations offer the advantage of steady-state levels without the peaks and valleys of injectable formulations 2.

Long-Acting Injectable (Testosterone Undecanoate)

• Initial dose: 750 mg intramuscularly, followed by 750 mg at 4 weeks, then 750 mg every 10 weeks 2

This formulation provides fewer injections yearly with less fluctuation but has restricted access in the United States due to risk of pulmonary oil microembolism 2.

Transdermal Patches

• Androderm: Start with 2-4 mg daily (one or two 2-mg patches) 2

Critical Monitoring After Initiation

Measure testosterone levels 3-6 months after starting therapy to ensure levels are in the mid-normal range 1. The timing of blood draws is formulation-specific:

• Injectable testosterone: Measure midway between injections; adjust if testosterone is >700 ng/dL or <400 ng/dL 1
• Transdermal gels: Measure any time after at least 1 week of treatment 1
• Transdermal patches: Measure 3-12 hours after application 1

Check hematocrit at baseline, 3-6 months, then annually. If hematocrit exceeds 54%, stop therapy until it decreases, evaluate for hypoxia/sleep apnea, and reinitiate at a reduced dose 1, 6.

Important Contraindications and Precautions

Baseline hematocrit above 50% is a relative contraindication because these men are more likely to develop hematocrit >54% on testosterone 1. These patients require further evaluation before considering therapy.

For men ≥40 years with baseline PSA >0.6 ng/mL, perform digital rectal examination and check PSA before treatment, at 3-6 months, then according to age-appropriate screening guidelines 1.

Dose Adjustment Strategy

The goal is to achieve mid-normal testosterone levels (approximately 400-700 ng/dL or 14-24 nmol/L), not supraphysiological levels 1, 6.

For injectable testosterone:

• If mid-interval testosterone is >700 ng/dL: reduce dose or increase frequency
• If mid-interval testosterone is <400 ng/dL: increase dose or decrease interval 1

For transdermal preparations: titrate dose to achieve mid-normal range based on steady-state levels 1, 6.

Common Pitfalls to Avoid

1. Don't start with excessively high doses: The dose-response relationship shows that higher doses increase muscle mass but also increase risks 7. Start conservatively and titrate.

2. Don't measure testosterone at the wrong time: Injectable testosterone levels fluctuate dramatically; measuring at peak or trough rather than mid-interval leads to inappropriate dose adjustments 1, 2.

3. Don't ignore hematocrit monitoring: Testosterone causes dose-dependent increases in hemoglobin, especially in older men 1. This is a major safety concern requiring regular monitoring.

4. Don't assume one-size-fits-all dosing: While 200 mg every 2 weeks is traditional for injectables, many patients do better with more frequent, smaller doses (e.g., 50-100 mg weekly) to minimize symptom fluctuations 3, 2, 5.

The evidence consistently supports starting with conservative doses and adjusting based on measured testosterone levels and clinical response rather than starting with maximum doses 1, 3, 1, 6.